DGTL

Serial Number 98638828
Registration 7699556
700

Registration Progress

Application Filed
Jul 9, 2024
Under Examination
Approved for Publication
Published for Opposition
Registered
Feb 18, 2025

Trademark Image

DGTL

Basic Information

Serial Number
98638828
Registration Number
7699556
Filing Date
July 9, 2024
Registration Date
February 18, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Feb 18, 2025
Registration
Registered
Classes
005

Rights Holder

Otsuka Pharmaceutical Co., Ltd.

99
Address
2-9 Kanda-Tsukasamachi,
Chiyoda-ku, Tokyo 101-8535
JP

Ownership History

Otsuka Pharmaceutical Co., Ltd.

Original Applicant
99
Chiyoda-ku, Tokyo JP

Otsuka Pharmaceutical Co., Ltd.

Original Registrant
99
Chiyoda-ku, Tokyo JP

Legal Representation

Attorney
Caroline Bryce

USPTO Deadlines

Next Deadline
1847 days remaining
Section 8 Declaration Due (Supplemental Register) (Based on registration date 20250218)
Due Date
February 18, 2031
Grace Period Ends
August 18, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

12 events
Date Code Type Description Documents
Feb 18, 2025 NRCS E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Feb 18, 2025 R.SR A REGISTERED-SUPPLEMENTAL REGISTER Loading...
Jan 27, 2025 CNTA O APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER Loading...
Jan 15, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 15, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 15, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 19, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Oct 19, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Oct 19, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 16, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 9, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 9, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of central nervous system diseases and disorders; pharmaceutical preparations for the treatment of central nervous system diseases and disorders, containing electronic chips which transmit information about drug ingestion by the patient

Classification

International Classes
005